The table below shows Protagonist Therapeutics, Inc's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$46.02M
$434.43M
$60.00M
$26.58M
$27.36M
$28.63M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$159.29M
$138.13M
$120.16M
$126.22M
$126.01M
$74.51M
SG&A
PTGX annual revenue (10-K history)
Protagonist Therapeutics, Inc reported annual revenue of $46.02M for fiscal year 2025. That is down 89.4% from $434.43M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $20.06M (FY 2017) to $46.02M. Figures come from the company's audited annual reports as filed with the SEC.